药石科技
(300725)
| 流通市值：83.96亿 | | | 总市值：96.84亿 |
| 流通股本：2.03亿 | | | 总股本：2.34亿 |
| 报告期 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 919,729,079.06 | 455,018,107.75 | 1,688,619,647.07 | 1,127,892,555.29 |
| 营业收入 | 919,729,079.06 | 455,018,107.75 | 1,688,619,647.07 | 1,127,892,555.29 |
| 二、营业总成本 | 829,705,605.73 | 412,531,258.48 | 1,441,959,716.75 | 1,011,642,933.42 |
| 营业成本 | 634,187,513.17 | 316,982,758.01 | 1,046,009,643.66 | 679,864,500.58 |
| 税金及附加 | 11,317,519.75 | 5,719,304.58 | 21,849,648 | 17,540,681.08 |
| 销售费用 | 30,891,836 | 15,143,093.02 | 57,304,723.22 | 42,985,096.24 |
| 管理费用 | 86,287,364.87 | 42,402,305.63 | 181,167,547.26 | 141,017,046.95 |
| 研发费用 | 48,352,749.39 | 21,559,149.46 | 107,330,053.84 | 88,967,345.69 |
| 财务费用 | 18,668,622.55 | 10,724,647.78 | 28,298,100.77 | 41,268,262.88 |
| 其中:利息费用 | 26,659,424.42 | 13,692,073.93 | 60,910,195.57 | 46,623,371.19 |
| 其中:利息收入 | 8,306,009.58 | 3,527,610.58 | 10,326,781.47 | 8,174,798.96 |
| 三、其他经营收益 | | | | |
| 加:公允价值变动收益 | -434,704.1 | -1,137,994.59 | 9,360,884.19 | 11,582,692.21 |
| 加:投资收益 | 11,059,877.09 | 4,356,576.46 | 35,436,886.52 | 28,565,584.66 |
| 资产减值损失(新) | -35,171,242.71 | -18,498,451.08 | -60,310,848.33 | -28,151,110.54 |
| 信用减值损失(新) | 10,199,575.32 | 6,243,874.59 | -5,492,532.66 | 2,100,449.72 |
| 其他收益 | 11,692,255.91 | 4,709,741.81 | 25,550,658.55 | 7,184,657.22 |
| 四、营业利润 | 87,369,234.84 | 38,160,596.46 | 251,204,978.59 | 137,531,895.14 |
| 加:营业外收入 | 186,690.63 | 137,509.09 | 428,349.9 | 12,430,579.45 |
| 减:营业外支出 | 1,284,663.14 | 358,770.53 | 2,737,450.77 | 1,963,547.52 |
| 五、利润总额 | 86,271,262.33 | 37,939,335.02 | 248,895,877.72 | 147,998,927.07 |
| 减:所得税费用 | 13,773,163.21 | 2,148,584.06 | 29,356,043.84 | 16,208,108.47 |
| 六、净利润 | 72,498,099.12 | 35,790,750.96 | 219,539,833.88 | 131,790,818.6 |
| (一)按经营持续性分类 | | | | |
| 持续经营净利润 | 72,498,099.12 | 35,790,750.96 | 219,539,833.88 | 131,790,818.6 |
| (二)按所有权归属分类 | | | | |
| 归属于母公司股东的净利润 | 72,498,099.12 | 35,790,750.96 | 219,539,833.88 | 131,790,818.6 |
| 扣除非经常损益后的净利润 | 59,621,052.27 | 30,537,131.92 | 173,124,567.76 | 87,731,073.62 |
| 七、每股收益 | | | | |
| (一)基本每股收益 | 0.36 | 0.18 | 1.1 | 0.66 |
| (二)稀释每股收益 | 0.36 | 0.18 | 1.1 | 0.66 |
| 八、其他综合收益 | 620,307,975.98 | -152,770.58 | 1,529,074.58 | -1,064,749.3 |
| 归属于母公司股东的其他综合收益 | 620,307,975.98 | -152,770.58 | 1,529,074.58 | -1,064,749.3 |
| 九、综合收益总额 | 692,806,075.1 | 35,637,980.38 | 221,068,908.46 | 130,726,069.3 |
| 归属于母公司股东的综合收益总额 | 692,806,075.1 | 35,637,980.38 | 221,068,908.46 | 130,726,069.3 |
| 公告日期 | 2025-08-08 | 2025-04-25 | 2025-04-25 | 2024-10-30 |
| 审计意见(境内) | | | 标准无保留意见 | |